Your browser doesn't support javascript.
loading
Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab.
Stuver, Robert; Vardhana, Santosha A; Bedmutha, Akshay; Chan, Karmela Kim; Mirtcheva-Trocheva, Rosna; Nosov, Anton; Schöder, Heiko; Moskowitz, Alison.
  • Stuver R; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Vardhana SA; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bedmutha A; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chan KK; Hospital for Special Surgery, New York, NY, USA.
  • Mirtcheva-Trocheva R; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nosov A; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Schöder H; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Moskowitz A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leuk Lymphoma ; 64(14): 2351-2353, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37794809
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article